Evidence map›Paper›PMID 28235050›Full record

ArticlePloS one2017

Modulation of functional characteristics of resident and thioglycollate-elicited peritoneal murine macrophages by a recombinant banana lectin.

Emilija Marinkovic, Radmila Djokic, Ivana Lukic, Ana Filipovic, Aleksandra Inic-Kanada, Dejana Kosanovic, Marija Gavrovic-Jankulovic, Marijana Stojanovic

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Emilija MarinkovicDepartment of Research and Development; Institute of Virology, Vaccines and Sera-TORLAK; Belgrade, Serbia.
Radmila DjokicDepartment of Research and Development; Institute of Virology, Vaccines and Sera-TORLAK; Belgrade, Serbia.
Ivana LukicDepartment of Research and Development; Institute of Virology, Vaccines and Sera-TORLAK; Belgrade, Serbia.
Ana FilipovicDepartment of Research and Development; Institute of Virology, Vaccines and Sera-TORLAK; Belgrade, Serbia.
Aleksandra Inic-KanadaOCUVAC-Center of Ocular Inflammation and Infection, Laura Bassi Centres of Expertise; Center for Pathophysiology, Infectiology and Immunology; Medical University of Vienna; Vienna, Austria.
Dejana KosanovicDepartment of Research and Development; Institute of Virology, Vaccines and Sera-TORLAK; Belgrade, Serbia.
Marija Gavrovic-JankulovicDepartment of Biochemistry, Faculty of Chemistry, University of Belgrade; Belgrade, Serbia.
Marijana StojanovicDepartment of Research and Development; Institute of Virology, Vaccines and Sera-TORLAK; Belgrade, Serbia.
Institute of Virology, Vaccines and Sera “Torlak” · RSMedical University of Vienna · ATUniversity of Belgrade · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We demonstrated that a recombinant banana lectin (rBanLec), which structural characteristics and physiological impacts highly resemble those reported for its natural counterparts, binds murine peritoneal macrophages and specifically modulates their functional characteristics. By using rBanLec in concentrations ranging from 1 μg to 10 μg to stimulate resident (RMs) and thioglycollate-elicited (TGMs) peritoneal macrophages from BALB/c and C57BL/6 mice, we have shown that effects of rBanLec stimulation depend on its concentration but also on the functional status of macrophages and their genetic background. rBanLec, in a positive dose-dependent manner, promotes the proliferation of TGMs from both BALB/c and C57BL/6 mice, while its mitogenic influence on RMs is significantly lower (BALB/c mice) or not detectable (C57BL/6 mice). In all peritoneal macrophages, irrespective of their type and genetic background, rBanLec, in a positive dose dependent manner, enhances the secretion of IL-10. rBanLec stimulation of RMs from both BALB/c and C57BL/6 resulted in a positive dose-dependent promotion of proinflammatory phenotype (enhancement of NO production and IL-12 and TNFα secretion, reduction of arginase activity). Positive dose-dependent skewing toward proinflammatory phenotype was also observed in TGMs from C57BL/6 mice. However, the enhancement of rBanLec stimulation promotes skewing of TGMs from BALB/c mice towards anti-inflammatory profile (reduction of NO production and IL-12 secretion, enhancement of arginase activity and TGFβ and IL-4 secretion). Moreover, we established that rBanLec binds oligosaccharide structures of TLR2 and CD14 and that blocking of signaling via these receptors significantly impairs the production of TNFα and NO in BALB/c macrophages. Since the outcome of rBanLec stimulation depends on rBanLec concentration as well as on the functional characteristics of its target cells and their genetic background, further studies are needed to investigate its effects under physiological and specific pathological conditions.

Indexed as

AnimalsArginaseCell ProliferationDose-Response Relationship, ImmunologicGene Expression RegulationImmunologic FactorsInterleukin-10Interleukin-12Lipopolysaccharide ReceptorsMacrophage ActivationMacrophages, PeritonealMiceMice, Inbred BALB CMice, Inbred C57BLNitric OxidePlant Lectins2-mercaptoacetateArginaseBanLec-IIL10 protein, mouseImmunologic FactorsInterleukin-10Interleukin-12Lipopolysaccharide ReceptorsNitric OxidePlant LectinsRecombinant ProteinsThioglycolatesTlr2 protein, mouseToll-Like Receptor 2Transforming Growth Factor betaTumor Necrosis Factor-alpha

Identifiers

PMID28235050
PMCPMC5325268
OpenAlexW2590903832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.